Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Stankovic, Sanja Dj (7005216636)"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention
    (2019)
    Matic, Dragan M (25959220100)
    ;
    Asanin, Milika R (8603366900)
    ;
    Vukcevic, Vladan D (15741934700)
    ;
    Mehmedbegovic, Zlatko H (55778381000)
    ;
    Marinkovic, Jelena M (7004611210)
    ;
    Kocev, Nikola I (6602672952)
    ;
    Marjanovic, Marija M (56437423000)
    ;
    Mrdovic, Igor B (10140828000)
    ;
    Antonijevic, Nebojsa M (6602303948)
    ;
    Milosevic, Aleksandra D (56622640900)
    ;
    Zivkovic, Milorad N (55959530600)
    ;
    Krljanac, Gordana V (8947929900)
    ;
    Stankovic, Sanja Dj (7005216636)
    ;
    Milasinovic, Dejan G (24823024500)
    ;
    Lasica, Ratko M (14631892300)
    ;
    Stankovic, Goran R (59150945500)
    Objectives The influence of the bleeding site on long-term survival after the primary percutaneous coronary intervention (PCI) is poorly understood. This study sought to investigate the relationship between in-hospital access site versus non-access site bleeding and very late mortality in unselected patients treated with primary PCI. Methods Data of the 2715 consecutive patients with ST-segment elevation myocardial infarction treated with primary PCI, enrolled in a prospective registry of a high volume tertiary centre, were analysed. Bleeding events were assessed according to the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 4-year mortality. Results The BARC type ≥2 bleeding occurred in 171 patients (6.3%). Access site bleeding occurred in 3.8%, and non-access site bleeding in 2.5% of patients. Four-year mortality was significantly higher for patients with bleeding (BARC type ≥2) than in patients without bleeding (BARC type 0+1), (36.3% vs 16.2%, p<0.001). Patients with non-access site bleeding had higher 4 year mortality (50.7% vs 26.5%, p=0.001). After multivariable adjustment, BARC type ≥2 bleeding was the independent predictor of 4 year mortality (HR 2.01; 95% CI 1.49 to 2.71, p<0.001). Patients with a non-access site bleeding were at 2-fold higher risk of very late mortality than patients with an access site bleeding (HR 2.62; 1.78 to 3.86, p<0.001 vs HR 1.57; 1.03 to 2.38, p=0.034). Conclusions Both access and non-access site BARC type ≥2 bleeding is independently associated with a high risk of 4-year mortality after primary PCI. Patients with non-access site bleeding were at higher risk of late mortality than patients with access site bleeding. © 2019 Author(s) (or their employer(s)).

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback